Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03308396
Title Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ajjai Alva, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Univerisity of Illinois Cancer Center Chicago Illinois 60612 United States Details
University of Iowa Hosptials and Clinics Iowa City Iowa 52242 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field